Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Oncology
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Oncology
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Devices
MedTech
J&J MedTech growth slows again as Abiomed weighs on results
J&J’s MedTech unit posted 3.6% operational growth in Q2, reaching $8.93 billion, as weaker Abiomed sales weighed on performance.
Ben Adams
Jul 15, 2026 9:57am
Medtronic recalls catheter delivery system that may detach
Jul 15, 2026 9:07am
‘Neural tourniquet’ could hold the key to stopping hemorrhaging
Jul 14, 2026 8:45am
IHealthScreen gets FDA nod for dx to spot diabetic retinopathy
Jul 10, 2026 8:55am
Novo Nordisk pens GLP-1 implant tech deal with Vivani Medical
Jul 7, 2026 9:07am
United Tx nabs FDA approval for donor-lung assessment device
Jun 29, 2026 9:27am
